A citation-based method for searching scientific literature

Izabela Rodrigues Figueiredo, Sara Cardoso Paes Rose, Nathália Bandeira Freire, Marina Stabile Patrocínio, Natália Pierdoná, Roberto José Bittencourt. Rev Assoc Med Bras (1992) 2019
Times Cited: 5







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials.
Robert Puckrin, Marie-Philippe Saltiel, Pauline Reynier, Laurent Azoulay, Oriana H Y Yu, Kristian B Filion. Acta Diabetol 2018
74
60


Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
Peter Ueda, Henrik Svanström, Mads Melbye, Björn Eliasson, Ann-Marie Svensson, Stefan Franzén, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Björn Pasternak. BMJ 2018
145
40

Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population-based study of older women and men with diabetes.
Iliana C Lega, Susan E Bronskill, Michael A Campitelli, Jun Guan, Nathan M Stall, Kenneth Lam, Lisa M McCarthy, Andrea Gruneir, Paula A Rochon. Diabetes Obes Metab 2019
36
40


Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll. PLoS One 2016
109
40



Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.
Chintan V Dave, Sebastian Schneeweiss, Dae Kim, Michael Fralick, Angela Tong, Elisabetta Patorno. Ann Intern Med 2019
49
40



Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis.
Jiali Liu, Ling Li, Sheyu Li, Pengli Jia, Ke Deng, Wenwen Chen, Xin Sun. Sci Rep 2017
86
40


Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
40

Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Subodh Verma, C David Mazer, Andrew T Yan, Tamique Mason, Vinay Garg, Hwee Teoh, Fei Zuo, Adrian Quan, Michael E Farkouh, David H Fitchett,[...]. Circulation 2019
168
40

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
40

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
40

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
40


Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management.
Orna Nitzan, Mazen Elias, Bibiana Chazan, Walid Saliba. Diabetes Metab Syndr Obes 2015
94
40

Fournier's gangrene in patients with type 2 diabetes using second-line antidiabetic medications.
Natalia Petruski-Ivleva, Sebastian Schneeweiss, Sara Eapen, Aditya Rajan, Saira Jan. Diabetes Obes Metab 2020
2
50

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.
Jason H Y Wu, Celine Foote, Juuso Blomster, Tadashi Toyama, Vlado Perkovic, Johan Sundström, Bruce Neal. Lancet Diabetes Endocrinol 2016
278
20




Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
Despoina Vasilakou, Thomas Karagiannis, Eleni Athanasiadou, Maria Mainou, Aris Liakos, Eleni Bekiari, Maria Sarigianni, David R Matthews, Apostolos Tsapas. Ann Intern Med 2013
527
20


Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.
Samy Suissa, Erica E M Moodie, Sophie Dell'Aniello. Pharmacoepidemiol Drug Saf 2017
75
20

Data Resource Profile: Clinical Practice Research Datalink (CPRD).
Emily Herrett, Arlene M Gallagher, Krishnan Bhaskaran, Harriet Forbes, Rohini Mathur, Tjeerd van Staa, Liam Smeeth. Int J Epidemiol 2015
20


Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes.
Christine Clar, James Alexander Gill, Rachel Court, Norman Waugh. BMJ Open 2012
149
20


Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Mei Zhang, Lin Zhang, Bin Wu, Haolan Song, Zhenmei An, Shuangqing Li. Diabetes Metab Res Rev 2014
82
20

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review.
Karin Rådholm, Jason Hy Wu, Muh Geot Wong, Celine Foote, Gregory Fulcher, Kenneth W Mahaffey, Vlado Perkovic, Bruce Neal. Diabetes Res Clin Pract 2018
42
20

Fournier's gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials.
Giovanni Antonio Silverii, Ilaria Dicembrini, Matteo Monami, Edoardo Mannucci. Diabetes Obes Metab 2020
9
20

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults.
Lorraine Lipscombe, Gillian Booth, Sonia Butalia, Kaberi Dasgupta, Dean T Eurich, Ronald Goldenberg, Nadia Khan, Lori MacCallum, Baiju R Shah, Scot Simpson. Can J Diabetes 2018
91
20

Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangrene.
Jeff Yufeng Yang, Tiansheng Wang, Virginia Pate, John B Buse, Til Stürmer. BMJ Open Diabetes Res Care 2020
5
20



Fournier's Gangrene: population based epidemiology and outcomes.
Mathew D Sorensen, John N Krieger, Frederick P Rivara, Joshua A Broghammer, Matthew B Klein, Christopher D Mack, Hunter Wessells. J Urol 2009
133
20

CNODES: the Canadian Network for Observational Drug Effect Studies.
Samy Suissa, David Henry, Patricia Caetano, Colin R Dormuth, Pierre Ernst, Brenda Hemmelgarn, Jacques Lelorier, Adrian Levy, Patricia J Martens, J Michael Paterson,[...]. Open Med 2012
87
20

An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.
Daniel S Hsia, Owen Grove, William T Cefalu. Curr Opin Endocrinol Diabetes Obes 2017
96
20


Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
20

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.
Sandeep R Das, Brendan M Everett, Kim K Birtcher, Jenifer M Brown, William T Cefalu, James L Januzzi, Rita Rastogi Kalyani, Mikhail Kosiborod, Melissa L Magwire, Pamela B Morris,[...]. J Am Coll Cardiol 2018
174
20

Dose response of sodium glucose cotransporter-2 inhibitors in relation to urinary tract infections: a systematic review and network meta-analysis of randomized controlled trials.
Jennifer R Donnan, Catherine A Grandy, Eugene Chibrikov, Carlo Marra PharmD, Kris Aubrey-Bassler, Karissa Johnston, Michelle Swab, Jenna Hache, Daniel Curnew, Hai Nguyen,[...]. CMAJ Open 2018
10
20

Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases.
Susan J Bersoff-Matcha, Christine Chamberlain, Christian Cao, Cindy Kortepeter, William H Chong. Ann Intern Med 2019
87
20





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.